ROYALTY PHARMA OA DL-0001ROYALTY PHARMA OA DL-0001ROYALTY PHARMA OA DL-0001

ROYALTY PHARMA OA DL-0001

No trades
See on Supercharts

Price target

38.650.000.00%
The 7 analysts offering 1 year price forecasts for RPD have a max estimate of — and a min estimate of —.

Analyst rating

Based on 11 analysts giving stock ratings to RPD in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


RPD EPS for the last quarter is 0.82 EUR despite the estimation of 0.83 EUR. In the next quarter EPS is expected to reach 0.92 EUR. Track more of ROYALTY PHARMA OA DL-0001 financials and stay on top of what is up with the company.
In the next quarter ROYALTY PHARMA OA DL-0001 revenue is expected to reach ‪581.39 M‬ EUR. Check out ROYALTY PHARMA OA DL-0001 revenue and earnings and make informed decisions.
According to analysts, RPD price target is 38.65 EUR with a max estimate of 47.25 EUR and a min estimate of 25.94 EUR. Check if this forecast comes true in a year, meanwhile watch ROYALTY PHARMA OA DL-0001 stock price chart and keep track of the current situation with RPD news and stock market news.
We've gathered opinions of 11 analysts rating RPD stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.